Dow Up 0.08% Nasdaq Down 0.30%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.17 Up 0.02(0.63%) Sep 19, 4:00PM EDT
Prev Close:3.15
Open:3.14
Bid:2.63 x 700
Ask:3.90 x 1000
1y Target Est:9.50
Beta:2.22
Next Earnings Date:N/A
Day's Range:3.08 - 3.17
52wk Range:2.88 - 5.25
Volume:60,072
Avg Vol (3m):86,098
Market Cap:71.88M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCUp 0.63%71.88M
AZNUp 0.76%94.37B
JNJUp 0.60%304.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):52.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback